Venture Capital Blog

Progentos Therapeutics Closes $65M Series A Financing

Progentos Therapeutics announced that it has successfully raised $65 million in a Series A funding round. Progentos is a Boston-based startup with the mission of developing groundbreaking treatments for diseases that affect nerve cells, such as Multiple Sclerosis (MS) and other demyelinating diseases.

Topics: venture capital Development Medtech

InStride Health's Series B: A $30m Boost for Pediatric Mental Health

InStride Health, a pioneering provider of pediatric anxiety and Obsessive Compulsive Disorder (OCD) treatments, has secured a monumental $30M in Series B funding. Under CEO John Voith's leadership, this Boston-based organization is setting new standards in mental health care for adolescents.

Topics: New Investors venture capital business insights Medtech

Revolutionizing Medical Device Testing: Adsilico Secures £3.5 Million for AI-Powered Breakthrough

Adsilico, a groundbreaking venture from the University of Leeds, has secured a £3.5 million seed investment towards transforming medical device testing. This infusion of funds, comprising £2 million from Northern Gritstone and £1.5 million from Parkwalk Advisors, marks a pivotal moment for the startup. 

Topics: venture capital investments Medtech